174 related articles for article (PubMed ID: 25343701)
21. Circumscribed choroidal hemangioma: clinical manifestations and factors predictive of visual outcome in 200 consecutive cases.
Shields CL; Honavar SG; Shields JA; Cater J; Demirci H
Ophthalmology; 2001 Dec; 108(12):2237-48. PubMed ID: 11733265
[TBL] [Abstract][Full Text] [Related]
22. Iris melanocytic tumours in New Zealand/Aotearoa: presentation, management and outcome in a high UV exposure environment.
Rapata MEJ; Zhang J; Cunningham WJ; Hadden PW; Patel DV; McGhee CNJ
Eye (Lond); 2023 Mar; 37(4):692-699. PubMed ID: 35338357
[TBL] [Abstract][Full Text] [Related]
23. Primary iris melanoma: diagnostic features and outcome of conservative surgical treatment.
Conway RM; Chua WC; Qureshi C; Billson FA
Br J Ophthalmol; 2001 Jul; 85(7):848-54. PubMed ID: 11423461
[TBL] [Abstract][Full Text] [Related]
24. Clinical Spectrum of Uveal Metastasis in Korean Patients Based on Primary Tumor Origin.
Kang HG; Kim M; Byeon SH; Kim SS; Koh HJ; Lee SC; Kim M
Ophthalmol Retina; 2021 Jun; 5(6):543-552. PubMed ID: 32942025
[TBL] [Abstract][Full Text] [Related]
25. Ciliary body medulloepithelioma: analysis of 41 cases.
Kaliki S; Shields CL; Eagle RC; Vemuganti GK; Almeida A; Manjandavida FP; Mulay K; Honavar SG; Shields JA
Ophthalmology; 2013 Dec; 120(12):2552-2559. PubMed ID: 23796765
[TBL] [Abstract][Full Text] [Related]
26. Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study.
Khan S; Finger PT; Yu GP; Razzaq L; Jager MJ; de Keizer RJ; Sandkull P; Seregard S; Gologorsky D; Schefler AC; Murray TG; Kivelä T; Giuliari GP; McGowan H; Simpson ER; Corriveau C; Coupland SE; Damato BE
Arch Ophthalmol; 2012 Jan; 130(1):57-64. PubMed ID: 21911649
[TBL] [Abstract][Full Text] [Related]
27. Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications.
Shields CL; Naseripour M; Shields JA; Freire J; Cater J
Am J Ophthalmol; 2003 May; 135(5):648-56. PubMed ID: 12719072
[TBL] [Abstract][Full Text] [Related]
28. Survey of 520 eyes with uveal metastases.
Shields CL; Shields JA; Gross NE; Schwartz GP; Lally SE
Ophthalmology; 1997 Aug; 104(8):1265-76. PubMed ID: 9261313
[TBL] [Abstract][Full Text] [Related]
29. Side Effects of Proton Beam Radiotherapy Treatment on Iris Melanoma.
Eibenberger K; Heimann H; Gatchalian L; Kacperek A; Hussain R
Ophthalmology; 2023 Sep; 130(9):958-965. PubMed ID: 37169262
[TBL] [Abstract][Full Text] [Related]
30. [Clinical analysis of tumors of the iris and ciliary body].
Liu GQ; Wu ZY; Feng GG; Yang HS; Yan JH; Zheng HL
Zhonghua Yan Ke Za Zhi; 2003 Feb; 39(2):77-80. PubMed ID: 12783684
[TBL] [Abstract][Full Text] [Related]
31. Visual Outcome and Millimeter Incremental Risk of Metastasis in 1780 Patients With Small Choroidal Melanoma Managed by Plaque Radiotherapy.
Shields CL; Sioufi K; Srinivasan A; Di Nicola M; Masoomian B; Barna LE; Bekerman VP; Say EAT; Mashayekhi A; Emrich J; Komarnicky L; Shields JA
JAMA Ophthalmol; 2018 Dec; 136(12):1325-1333. PubMed ID: 30267070
[TBL] [Abstract][Full Text] [Related]
32. Uveal metastasis from breast cancer in 264 patients.
Demirci H; Shields CL; Chao AN; Shields JA
Am J Ophthalmol; 2003 Aug; 136(2):264-71. PubMed ID: 12888048
[TBL] [Abstract][Full Text] [Related]
33. Clinical survey of 3680 iris tumors based on patient age at presentation.
Shields CL; Kancherla S; Patel J; Vijayvargiya P; Suriano MM; Kolbus E; Badami A; Sharma P; Jacobs E; Voluck M; Zhang Z; Kansal R; Shields PW; Bianciotto CG; Shields JA
Ophthalmology; 2012 Feb; 119(2):407-14. PubMed ID: 22035581
[TBL] [Abstract][Full Text] [Related]
34. Uveal Metastasis: Clinical Features and Survival Outcome of 2214 Tumors in 1111 Patients Based on Primary Tumor Origin.
Shields CL; Welch RJ; Malik K; Acaba-Berrocal LA; Selzer EB; Newman JH; Mayro EL; Constantinescu AB; Spencer MA; McGarrey MP; Knapp AN; Graf AE; Altman AJ; Considine SP; Shields JA
Middle East Afr J Ophthalmol; 2018; 25(2):81-90. PubMed ID: 30122853
[TBL] [Abstract][Full Text] [Related]
35. Recurrence of iris melanoma after proton beam therapy.
Sandinha MT; Kacperek A; Errington RD; Coupland SE; Damato B
Br J Ophthalmol; 2014 Apr; 98(4):484-7. PubMed ID: 24414401
[TBL] [Abstract][Full Text] [Related]
36. Plaque radiotherapy in the management of scleral-invasive conjunctival squamous cell carcinoma: an analysis of 15 eyes.
Arepalli S; Kaliki S; Shields CL; Emrich J; Komarnicky L; Shields JA
JAMA Ophthalmol; 2014 Jun; 132(6):691-6. PubMed ID: 24557333
[TBL] [Abstract][Full Text] [Related]
37. Juvenile Xanthogranuloma Involving the Eye and Ocular Adnexa: Tumor Control, Visual Outcomes, and Globe Salvage in 30 Patients.
Samara WA; Khoo CT; Say EA; Saktanasate J; Eagle RC; Shields JA; Shields CL
Ophthalmology; 2015 Oct; 122(10):2130-8. PubMed ID: 26189188
[TBL] [Abstract][Full Text] [Related]
38. Proton beam therapy for presumed and confirmed iris melanomas: a review of 36 cases.
Rahmi A; Mammar H; Thariat J; Angellier G; Herault J; Chauvel P; Kodjikian L; Denis P; Grange JD
Graefes Arch Clin Exp Ophthalmol; 2014 Sep; 252(9):1515-21. PubMed ID: 25038910
[TBL] [Abstract][Full Text] [Related]
39. Proton beam radiotherapy of iris melanoma.
Damato B; Kacperek A; Chopra M; Sheen MA; Campbell IR; Errington RD
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):109-15. PubMed ID: 16111578
[TBL] [Abstract][Full Text] [Related]
40. Iris nevus growth into melanoma: analysis of 1611 consecutive eyes: the ABCDEF guide.
Shields CL; Kaliki S; Hutchinson A; Nickerson S; Patel J; Kancherla S; Peshtani A; Nakhoda S; Kocher K; Kolbus E; Jacobs E; Garoon R; Walker B; Rogers B; Shields JA
Ophthalmology; 2013 Apr; 120(4):766-72. PubMed ID: 23290981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
